ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันศุกร์ที่ ๙ ธันวาคม พ.ศ. ๒๕๕๙ ๒๐:๒๙ น.

Food and Healthcare Press Releases

Mental Health in the Digital Age Heathcare—๒ ธ.ค. ๕๙

Forgetting someone's name, not remembering where you parked the car, misplacing your phone or forgetting why you came into the kitchen – these are very common memory lapses we experience from time to time. But more and more, these moments don't

Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer#s Disease (CTAD) 2016 Meeting Heathcare—๙ ธ.ค. ๕๙

INDIANAPOLIS--9 Dec--PRNewswire/InfoQuest

Eli Lilly and Company (NYSE:LLY) today presented detailed results of its phase 3 EXPEDITION3 trial at the 9th Clinical Trials on Alzheimer's Disease (CTAD) meeting. As previously disclosed, solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a study of solanezumab initiated in people with mild dementia due to Alzheimer's disease (AD), and Lilly will not pursue regulatory submissions for solanezumab for the treatment of mild dementia due to AD.

"The results of EXPEDTION3 are without question disappointing," said Eric Siemers, M.D., distinguished medical fellow at Lilly. "However, Lilly remains committed to finding solutions for this devastating disease. We will continue to analyze study results and work with the external scientific community in the hopes of uncovering findings that will help shape and advance future Alzheimer's disease research."

Lawrence S. Honig, M.D., Ph.D., professor of neurology at Columbia University Medical Center and principal investigator of the EXPEDITION3 study, presented the data at the meeting.

"Alzheimer's is a challenging disease that researchers have been committed to studying for some years," Dr. Honig said. "Now is not the time to give up. While the outcome of this study is not what we had hoped for, it is reasona

OGT Releases Targeted NGS Panel to Study SNV and CNV in Familial Hypercholesterolemia Heathcare—๙ ธ.ค. ๕๙

Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its customisable SureSeq(TM) NGS panel range with the launch of the SureSeq myPanel(TM) NGS Custom FH Panel - allowing fast and cost-effective study of variants in familial

Mederi#s Stretta Therapy for GERD approved in China Heathcare—๙ ธ.ค. ๕๙

Clinically proven and cost effective solution for gastroesophageal reflux disease recently launched in China. Mederi Therapeutics Inc. has announced regulatory approval by CFDA and product launch in China for Stretta Therapy, a non-surgical treatment

Nordion and General Atomics welcome US National Nuclear Security Administration Phase II funding Heathcare—๘ ธ.ค. ๕๙

Nordion, a standalone business of Sterigenics International, in partnership with General Atomics (GA), welcome today's award by the United States Department of Energy's (DOE) National Nuclear Security Administration (NNSA) of the Phase II cooperative

Merck#s Consumer Health Business Drives Consumer-Centric, Purposeful Heathcare—๖ ธ.ค. ๕๙

- Innovation and digital presence identified as main drivers of successful engagement with consumers and healthcare professionals Merck, a leading science and technology company, has developed a novel approach to product co-creation for its Consumer

NovoSeven(R) Resolved 96.5% of Bleeds When Initiated Within One Hour After Bleed Onset in People Heathcare—๖ ธ.ค. ๕๙

Novo Nordisk today announced that NovoSeven(R) (rFVIIa), a portable room temperature stable recombinant activated factor VIIa, resolved 96.5% of bleeds when initiated within one hour after onset of bleeding, demonstrating efficacy of early treatment in

Xultophy(R) Demonstrates Similar Glucose Control with Reduced Risk of Hypoglycaemia and a Superior Heathcare—๒ ธ.ค. ๕๙

Novo Nordisk today announced new phase 3b trial (DUAL VII) results with Xultophy(R) (IDegLira). Xultophy(R) is a once-daily, single injection fixed combination of a long-acting basal insulin (insulin degludec) and a glucagon-like peptide-1 (GLP-1)

bioLytical Introduces INSTI HIV Self Test to Kenyan Regulated Pharmacy Heathcare—๒ ธ.ค. ๕๙

bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the Company's newest product, the INSTI HIV Self Test, to Kenya's Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905

bioLytical Launches INSTI HIV Self Test for African Market in Response to New WHO Heathcare—๒ ธ.ค. ๕๙

bioLytical Laboratories (the "Company"), a world leader in rapid infectious disease tests, announced today it is expanding the launch of its INSTI HIV Self Test to Africa with a lower cost version starting this month. Photo -

Merck Expands Distribution Agreement with Roche Heathcare—๒ ธ.ค. ๕๙

- Merck to be the exclusive supplier of novel enzymes for polymerase chain reaction (PCR) and quantitative real-time PCR, for all countries except the U.S., Brazil and Japan - Exclusive global distributor for Roche's biochemical reagents portfolio since

GSK leads Access to Medicine Index 2016 Index describes GSK as #the most access-oriented Heathcare—๓๐ พ.ย. ๕๙

GSK has today been ranked first in the Access to Medicine Index for the fifth consecutive time, taking a leadership position in research & development; pricing, manufacturing and distribution of medicines; and product donations. The Index, which

Global research network hunts the missing link between genetics and environmental factors to unlock Heathcare—๓๐ พ.ย. ๕๙

-- The International Phenome Centre Network (IPCN) of leading global research institutions works to transform healthcare through phenomics - the dynamic interactions between our genes and our environment. -- Phenomics can advance precision medicine

FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Heathcare—๓๐ พ.ย. ๕๙

- If approved by the FDA, avelumab, an investigational immunotherapy, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma (MCC) - Avelumab has previously received FDA Breakthrough Therapy and Fast Track Designations

Give a Gift that Will Last a Lifetime this Holiday Season with Smile Heathcare—๓๐ พ.ย. ๕๙

In celebration of #GivingTuesday and the holiday giving season, Smile Train , the world's largest cleft organization, launched its new " Give Smiles " campaign today to help more children around the world smile and live happier, healthier lives. From

Treatment Brings New Hope for Patients Suffering From Fatal Lung Disease From Fatal Lung Heathcare—๒๕ พ.ย. ๕๙

Idopathic Pulmonary Fibrosis (IPF) is a debilitating and fatal lung disease that currently affects approximately 3 million people worldwide with a median survival of 2-3 years after diagnosis (1)(2). It is a silent killer that many are not aware of.

Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial Heathcare—๒๔ พ.ย. ๕๙

Eli Lilly and Company (NYSE: LLY) today announced that solanezumab did not meet the primary endpoint in the EXPEDITION3 clinical trial, a phase 3 study of solanezumab in people with mild dementia due to Alzheimer's disease (AD). Patients treated with

Newly Published Case Series: Stretta as a Treatment Option for GERD in the Bariatric Heathcare—๒๓ พ.ย. ๕๙

Mederi Therapeutics Inc., manufacturers of Stretta Therapy for gastroesophageal reflux disease (GERD), announced the publication of a case series demonstrating the viability of Stretta Therapy as a treatment for chronic GERD after a Laparoscopic Sleeve

OGT Announces Commercial and Financial Highlights for FY 2016 Heathcare—๒๓ พ.ย. ๕๙

Highly integrated molecular genetics portfolio delivers significant revenue growth and sustainable profit Oxford Gene Technology (OGT), The Molecular Genetics Company has announced continued strong sales of its highly integrated molecular genetics

HIMSS ผนึกกำลัง CHIME พลิกโฉมแวดวงสุขภาพระดับโลก Heathcare—๒๒ พ.ย. ๕๙

Healthcare Information and Management Systems Society (HIMSS) และ College of Health Information Management Executives (CHIME) บรรลุข้อตกลงเป็นพันธมิตรในทุกโครงการและทุกชุมชนผู้เชี่ยวชาญนอกอเมริกาเหนือ ภายใต้ชื่อ HIMSS-CHIME International

Leading Healthcare IT Organizations Partner to Expand Global Impact Heathcare—๒๒ พ.ย. ๕๙

The Healthcare Information and Management Systems Society (HIMSS) and the College of Health Information Management Executives (CHIME) announced a pivotal agreement to jointly partner on all programs and professional communities outside of North America.

Breaking the Global Scientific Supremacy through Open Access Journals Heathcare—๒๒ พ.ย. ๕๙

Quality Science Produced from Asian and other non-English speaking Countries is not getting cited and reaching the scientific fraternity. Dr. Srinubabu Gedela , CEO, OMICS International , said, open access journals are all set to break the supremacy

OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Heathcare—๒๒ พ.ย. ๕๙

COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced deliverability OrbusNeich has announced the launch of its latest generation Dual Therapy Stent (DTS), the COMBO

Tillotts Pharma AG Introduces the New Technology OPTICORE(TM) (OPTImized COlonic RElease) for Heathcare—๒๑ พ.ย. ๕๙

Tillotts Pharma AG (Switzerland) introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists. The OPTICORE(TM) coating technology comprises two trigger systems